首頁 > 市場調查報告書 > 製藥

感染疾病

市場調查報告書

商品編碼

1386140

腺病毒疫苗市場報告：2030 年趨勢、預測與競爭分析

Adenovirus Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: 2023年10月03日 | 出版商:

Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

腺病毒疫苗趨勢與預測

預計到 2030 年，全球腺病毒疫苗市場將達到 14 億美元，2024 年至 2030 年年複合成長率為 7.5%。該市場的主要促進因素是癌症基因療法疫苗接種需求的激增以及製藥公司疫苗接種需求的激增。全球腺病毒疫苗市場的未來看起來充滿希望，研究/學術、實驗室和製藥/生物技術市場存在商機。

腺病毒疫苗市場洞察

Lucintel 預測，由於 7 型疫苗的經濟性和提供即時免疫力的能力，預計在預測期內將出現強勁成長。

由於腺病毒感染的高流行和人口的持續成長，預計北美在預測期內將經歷最高的成長。

市場規模/估計：以金額的腺病毒疫苗市場規模估計（10 億美元）。

趨勢和預測分析：各個細分市場和地區的市場趨勢（2018-2023）和預測（2024-2030）。

細分分析：按類型、應用和區域金額（十億美元）估計腺病毒疫苗市場規模。

區域分析：北美、歐洲、亞太地區和世界其他地區的腺病毒疫苗市場區隔。

成長機會：按類型、應用和區域對腺病毒疫苗市場進行成長機會分析。

策略分析：腺病毒疫苗市場併購、新產品開發、競爭形勢等。

基於波特五力模型的產業競爭實力分析。

本報告回答了 11 個關鍵問題：

Q.1. 細分市場中最有前途和高成長的機會是什麼？
Q.2.哪個細分市場將以更快的速度成長？為什麼？
Q.3.您認為哪些地區未來會出現更快的成長？為什麼？
Q.4. 影響市場動態的主要因素有哪些？市場的主要挑戰和商業風險是什麼？
Q.5. 這個市場的商業風險和競爭威脅是什麼？
Q.6.這個市場有哪些新趨勢？為什麼？
Q.7.市場客戶需求有何改變？
Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

成長機會分析
- 按類型分類的全球腺病毒疫苗市場成長機會
- 全球腺病毒疫苗市場成長機會（按應用）
- 全球腺病毒疫苗市場成長機會（按地區）
全球腺病毒疫苗市場的新趨勢
戰略分析
- 新產品開發
- 全球腺病毒疫苗市場產能擴張
- 全球腺病毒疫苗市場的合併、收購與合資
- 認證和許可

第7章主要企業概況

Novasep
Charles River Laboratories
uniQure
Waisman Biomanufacturing
Creative-Biogene
Aldevron
Addgene
Thermo Fisher Scientific
Fujifilm Corporation
Spark Therapeutics

簡介目錄

Adenovirus Vaccine Trends and Forecast

The future of the global adenovirus vaccine market looks promising with opportunities in the research and academic, laboratories, and pharmaceutical & biotechnology markets. The global adenovirus vaccine market is expected to reach an estimated $1.4 billion by 2030 with a CAGR of 7.5% from 2024 to 2030. The major drivers for this market are the rapidly increasing need for vaccinations in cancer gene therapies and surge in vaccination demand from pharmaceutical companies.

A more than 150-page report is developed to help in your business decisions.

Adenovirus Vaccine by Segment

The study includes a forecast for the global adenovirus vaccine by type, application, and region.

Adenovirus Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:

Type 4 Vaccine
Type 7 Vaccine

Adenovirus Vaccine Market by Application [Shipment Analysis by Value from 2018 to 2030]:

Research and Academic
Laboratories
Pharmaceutical & Biotechnology

Adenovirus Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

North America
Europe
Asia Pacific
The Rest of the World

List of Adenovirus Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies adenovirus vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the adenovirus vaccine companies profiled in this report include-

Novasep
Charles River Laboratories
Uniqure
Waisman Biomanufacturing
Creative-Biogene
Aldevron
Addgene
Thermo Fisher Scientific
Fujifilm Corporation
Spark Therapeutics

Adenovirus Vaccine Market Insights

Lucintel forecasts that type 7 vaccine is expected to witness higher growth over the forecast period due to its affordability and ability to instantly confer immunity.

North America is expected to witness highest growth over the forecast period due to due to the high prevalence of adenovirus infection and continuous population growth in the region.

Features of the Global Adenovirus Vaccine Market

Market Size Estimates: Adenovirus vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Adenovirus vaccine market size by type, application, and region in terms of value ($B).

Regional Analysis: Adenovirus vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the adenovirus vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the adenovirus vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the adenovirus vaccine market size?

Answer: The global adenovirus vaccine market is expected to reach an estimated $1.4 billion by 2030.

Q.2 What is the growth forecast for adenovirus vaccine market?

Answer: The global adenovirus vaccine market is expected to grow with a CAGR of 7.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the adenovirus vaccine market?

Answer: The major drivers for this market are the rapidly increasing need for vaccinations in cancer gene therapies and surge in vaccination demand from pharmaceutical companies.

Q4. What are the major segments for adenovirus vaccine market?

Answer: The future of the adenovirus vaccine market looks promising with opportunities in the research and academic, laboratories, and pharmaceutical & biotechnology markets.

Q5. Who are the key adenovirus vaccine market companies?

Answer: Some of the key adenovirus vaccine companies are as follows:

Novasep
Charles River Laboratories
Uniqure
Waisman Biomanufacturing
Creative-Biogene
Aldevron
Addgene
Thermo Fisher Scientific
Fujifilm Corporation
Spark Therapeutics

Q6. Which adenovirus vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that type 7 vaccine is expected to witness higher growth over the forecast period due to its affordability and ability to instantly confer immunity.

Q7. In adenovirus vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to due to the high prevalence of adenovirus infection and continuous population growth in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the adenovirus vaccine market by type (type 4 vaccine and type 7 vaccine), application (research and academic, laboratories, and pharmaceutical & biotechnology), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

1. Executive Summary

2. Global Adenovirus Vaccine Market : Market Dynamics

2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Adenovirus Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Adenovirus Vaccine Market by Type
- 3.3.1: Type 4 Vaccine
- 3.3.2: Type 7 Vaccine
3.4: Global Adenovirus Vaccine Market by Application
- 3.4.1: Research and Academic
- 3.4.2: Laboratories
- 3.4.3: Pharmaceutical & Biotechnology

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

4.1: Global Adenovirus Vaccine Market by Region
4.2: North American Adenovirus Vaccine Market
- 4.2.2: North American Adenovirus Vaccine Market by Application: Research and Academic, Laboratories, and Pharmaceutical & Biotechnology
4.3: European Adenovirus Vaccine Market
- 4.3.1: European Adenovirus Vaccine Market by Type: Type 4 Vaccine and Type 7 Vaccine
- 4.3.2: European Adenovirus Vaccine Market by Application: Research and Academic, Laboratories, and Pharmaceutical & Biotechnology
4.4: APAC Adenovirus Vaccine Market
- 4.4.1: APAC Adenovirus Vaccine Market by Type: Type 4 Vaccine and Type 7 Vaccine
- 4.4.2: APAC Adenovirus Vaccine Market by Application: Research and Academic, Laboratories, and Pharmaceutical & Biotechnology
4.5: ROW Adenovirus Vaccine Market
- 4.5.1: ROW Adenovirus Vaccine Market by Type: Type 4 Vaccine and Type 7 Vaccine
- 4.5.2: ROW Adenovirus Vaccine Market by Application: Research and Academic, Laboratories, and Pharmaceutical & Biotechnology

5. Competitor Analysis

5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

6.1: Growth Opportunity Analysis
- 6.1.1: Growth Opportunities for the Global Adenovirus Vaccine Market by Type
- 6.1.2: Growth Opportunities for the Global Adenovirus Vaccine Market by Application
- 6.1.3: Growth Opportunities for the Global Adenovirus Vaccine Market by Region
6.2: Emerging Trends in the Global Adenovirus Vaccine Market
6.3: Strategic Analysis
- 6.3.1: New Product Development
- 6.3.2: Capacity Expansion of the Global Adenovirus Vaccine Market
- 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Adenovirus Vaccine Market
- 6.3.4: Certification and Licensing